Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Annual Revenue ($)

Elanco revenue was $3.27 b in FY, 2020

Quarterly Revenue ($)

FY, 2017FY, 2018FY, 2019FY, 2020
Revenue$2.89 b$3.07 b$3.07 b$3.27 b
Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020
Revenue$736.2 m$770.2 m$761.1 m$731.1 m$781.6 m$771.3 m$657.7 m$586.3 m$889.6 m

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Elanco revenue breakdown by business segment: 25.7% from CA Disease Prevention, 11.3% from CA Therapeutics, 24.3% from FA Future Protein & Health, 36.2% from FA Ruminants & Swine and 2.6% from Other

FY, 2017FY, 2019FY, 2018
CA Disease Prevention$660.2 m$787.9 m$804.6 m
CA Therapeutics$260.8 m$348 m$283.1 m
FA Future Protein & Health$649.2 m$745.1 m$711.2 m
FA Ruminants & Swine$1.18 b$1.11 b$1.17 b
Strategic Exits$143.8 m$79.7 m$93.9 m

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu